alpha-aminopyridine has been researched along with Fatigue in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bohemier, C; Cabanero, M; Chen, E; Goodwin, R; Jonker, D; Kennecke, H; Lim, H; Ritter, H; Seymour, L; Tsao, MS; Tu, D; Vickers, M | 1 |
| Bradley, KM; Campo, L; Fenwick, JD; Gleeson, FV; Green, M; Higgins, GS; Horne, A; Macpherson, RE; Maughan, TS; McCole, MG; McGowan, DR; McKenna, WG; Mohammed, S; Muschel, RJ; Ng, SM; Panakis, N; Prevo, R; Skwarski, M; Strauss, VY; Stuart, R; Tacconi, EMC; Vallis, KA | 1 |
| Cersosimo, RJ | 1 |
| Bai, O; Cai, Z; Chen, X; Ding, K; Dong, M; Gao, Y; He, H; Hou, M; Huang, H; Huang, X; Jia, B; Jin, J; Jin, Z; Li, W; Li, X; Li, Z; Liang, R; Liu, L; Liu, P; Liu, Q; Liu, T; Luo, J; Luo, Y; Qiu, L; Shen, J; Shi, Y; Song, Y; Su, H; Su, L; Sun, X; Sun, Z; Tan, H; Tang, X; Wang, H; Wang, J; Wang, S; Wang, X; Wu, G; Wu, J; Xu, J; Xu, W; Yang, H; Yang, J; Yi, P; Zeng, Q; Zhang, H; Zhang, L; Zhang, X; Zhang, Y; Zhang, Z; Zhao, W; Zhou, D; Zhou, J | 1 |
| Genovese, MC; Grossbard, EB; Jones, DA; Kavanaugh, A; Magilavy, DB; Musser, TK; Weinblatt, ME | 1 |
| Hohlfeld, R; Zimmermann, C | 1 |
| Waubant, E | 1 |
| Heusinger, JH | 1 |
2 review(s) available for alpha-aminopyridine and Fatigue
| Article | Year |
|---|---|
Cyclin-dependent kinase 4/6 inhibitors for the management of advanced or metastatic breast cancer in women.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Breast Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Dose-Response Relationship, Drug; Fatigue; Female; Gastrointestinal Diseases; Humans; Molecular Targeted Therapy; Neoplasm Staging; Neutropenia; Piperazines; Progression-Free Survival; Protein Kinase Inhibitors; Purines; Pyridines; Randomized Controlled Trials as Topic | 2019 |
['Fatigue' in multiple sclerosis].
Topics: Amantadine; Aminopyridines; Disease Progression; Fatigue; Female; Humans; Male; Multiple Sclerosis; Pemoline; Potassium Channel Blockers; Severity of Illness Index | 1999 |
4 trial(s) available for alpha-aminopyridine and Fatigue
| Article | Year |
|---|---|
A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancer.
Topics: Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Exanthema; Fatigue; Female; Humans; Male; Middle Aged; Morpholines; Mucositis; Panitumumab; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase | 2020 |
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.
Topics: Adenocarcinoma of Lung; Aged; Aminopyridines; Anorexia; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Fatigue; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Misonidazole; Morpholines; Nausea; Phosphoinositide-3 Kinase Inhibitors; Positron Emission Tomography Computed Tomography; Radiation-Sensitizing Agents; Radiotherapy; Tumor Hypoxia | 2019 |
Effects of fostamatinib (R788), an oral spleen tyrosine kinase inhibitor, on health-related quality of life in patients with active rheumatoid arthritis: analyses of patient-reported outcomes from a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aminopyridines; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Fatigue; Female; Humans; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; Morpholines; Motor Activity; Oxazines; Pain; Pain Measurement; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Quality of Life; Severity of Illness Index; Syk Kinase; Treatment Outcome | 2013 |
Efficacy and tolerance of flupirtine and pentazocine in two multicentre trials.
Topics: Administration, Oral; Administration, Rectal; Aminopyridines; Analgesics; Clinical Trials as Topic; Drug Tolerance; Fatigue; Humans; Palliative Care; Pentazocine | 1987 |
3 other study(ies) available for alpha-aminopyridine and Fatigue
| Article | Year |
|---|---|
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminopyridines; Anemia; Antineoplastic Combined Chemotherapy Protocols; Benzamides; China; Disease-Free Survival; Fatigue; Female; Histone Deacetylase Inhibitors; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neutropenia; Recurrence; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult | 2017 |
[Efficient treatment of chronic backache].
Topics: Aminopyridines; Analgesics; Back Pain; Chronic Disease; Fatigue; Humans; Pilot Projects; Polysomnography; Quality of Life; Sleep Wake Disorders; Surveys and Questionnaires; Time Factors | 2009 |
[Therapeutic indications for managing symptoms: fatigue].
Topics: Amantadine; Aminopyridines; Double-Blind Method; Fatigue; Humans; Multiple Sclerosis; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |